FDA’s first two warning letters since draft compounding guidances may be another way to encourage outsourcer registration.

Letters seek help encouraging large-scale compounders to register with the agency as outsourcing facilities; FDA also seeks nominations for its compounding advisory committee.

FDA will enforce USP standards, a regulatory first.

As bill heads to President, voluntary registration system for compounders likely means not all large-scale operations will subject themselves to FDA oversight.